Rivio

Paying for outcomes instead of licences is the bargain Rivio offers Brazilian hospitals. The company, which describes itself as a healthcare AI services company, combines AI agents with health specialists to operate critical hospital functions, and ties its own revenue to the result. It was founded in 2025 by Ricardo Sales and Silvio Frison, who is its chief executive, and it keeps offices in São Paulo and Blumenau.

A revenue cycle run from care to payment

Rivio starts from the revenue cycle, the steps between delivering care and receiving payment from health insurers. Its Financial AI Service takes over that cycle from end to end. AI agents cross-check the medical record, the bill and the insurer's rules before, during and after treatment, while specialists handle the particularities of each hospital. The company describes a Command Center that tracks the status, exceptions and performance of every batch of claims, a billing process that sends accounts and batches on time, and a team that analyses and contests denied items before they become losses. Its remuneration is linked to performance, and it says it answers for the outcome under contract.

Five more services still being built

The site lists further services under development: an Operational AI Service for beds, operating rooms and supplies, Administrative Intelligence for authorisations, eligibility and clinical coding, a Clinical Support AI Service for documentation and decision support, Robotics Orchestration, and a Digital Twin of the hospital. Rivio says it works on top of the systems a hospital already has. It presents a manifesto arguing that health care needs engineers who treat hospital waste as a badly designed system, and a nine-member advisory board of hospital executives and technology figures.

Hospitals, investors and the Series A extension

According to its own news post of 4 November 2026, Rivio operates in 13 hospital groups and names Albert Einstein, Sírio-Libanês, Oswaldo Cruz, A.C.Camargo Cancer Center, Hcor, São Camilo and AACD among its clients. The post announces an extension of its Series A of R$ 180 million, led by Valor Capital Group with Monashees, Positive Ventures and APL, at a valuation above R$ 1 billion. Endeavor Catalyst had invested in earlier rounds. The company says it aims to become the main operating system for health care in Latin America.

Key facts

Founded: 2025, by Ricardo Sales and Silvio Frison Headquarters: R. Pamplona, 771, 9th floor, São Paulo, SP, Brazil; second office at R. Dr. Léo de Carvalho, 74, Blumenau, SC People: Silvio Frison (co-founder and CEO); Ricardo Sales (co-founder) Customers: 13 hospital groups, including Albert Einstein, Sírio-Libanês, Oswaldo Cruz, A.C.Camargo, Hcor, São Camilo and AACD (company statement) Products or Services: Financial AI Service for the hospital revenue cycle; further services in development Funding: Series A extension of R$ 180 million led by Valor Capital Group, announced 4 November 2026 Website: rivio.com.br